U.S. Court Invalidates Patent on J & J Cancer Drug Zytiga U.S. Court Invalidates Patent on J & J Cancer Drug Zytiga

A U.S. administrative court on Wednesday invalidated a Johnson& Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news